Everything below concerns REV-ERB agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
==== Protein reduction ==== In order to combat uraemia, the amount of protein in the diet and thus the amount of nitrogen supplied to the body can be reduced. However, this is only possible to a limited extent in cats, as their energy balance is dependent on protein (see above). The protein content should be adjusted to the maintenance requirement of 15 g digestible crude protein per MJ UE and should never be reduced below 11 g/MJ UE, whereby the amount of protein declared on feed must be multiplied by a factor of 0.86 to obtain the digestible crude protein. High-quality animal protein also reduces the amount of nitrogen compounds entering the large intestine and thus the amount of ammonia produced by bacterial degradation processes through the intestinal flora. If there are severe acceptance problems or there is a loss of body mass and muscle, complicating factors (metabolic acidosis, intestinal bleeding) must be clarified. The necessary nutritional requirements must be guaranteed in any case, in problematic cases even without a kidney diet.
For years I have been endeavouring to find a credible thesis for the development of Buddhist art, and primarily to trace the ancient route by which the art of imperial Rome, etc..., reached the Far East. What I have seen here goes beyond my wildest dreams. If only I had hands enough to copy it all, [for] here in Kizil are about 300 caves, some of them containing frescoes, all of them very old and fine." The French explorer Paul Pelliot and his photographer Charles Nouette, who were in Kucha from January 1907, visited Kizil soon after the German mission, from September 1, 1907, over a few days, and Charles Nouette took many beautiful and informative photographs. Albert von Le Coq came back to Kizil and surrounding areas in 1913–1914, heading the Fourth German Expedition, removing many paintings, including those Grünwedel had left in place, but generally taking much fewer records than his predecessor.
== Reception == Half-Life 2: Deathmatch was well-received upon its release, with reviewers praising its inclusion of the gravity gun. GameSpot lauded the game for the Source engine's "impressive use of physics" and the available selection of maps. IGN paid similar compliments to the title, also speaking highly of the "fast play style that [Half-Life 2: Deathmatch] produces." Multiple reviews stated that the game suffered from large amount of lag upon release, but GameSpy noted that this was remedied soon after as more servers came online.
A 2019 trial in 30 healthy men who fasted for 24 hours showed a 25–30% reduction in hunger scores with Amarasate compared to the placebo. In a 2022 randomized, crossover study of 19 healthy-weight men, Amarasate reduced energy intake by 18% at an ad libitum meal. It also significantly elevated GLP-1 and CCK levels. A 2024 study involving 30 healthy adult women under fasting conditions found a 40% reduction in food cravings, along with a 30% drop in hunger and a 14.3% reduction in rebound eating. In a 2026 24-week placebo-controlled study of adults, Amarasate was shown to reduce body weight by 5.3% and significantly lower both total and visceral body fat, without any loss to lean muscle mass.
All work in Berlin ceased by July. Hahn and his family moved to the house of a textile manufacturer there. Life became precarious for those married to Jewish women. One was Philipp Hoernes, a chemist working for Auergesellschaft, the firm that mined the uranium ore used by the project. After the firm let him go in 1944, Hoernes faced being conscripted for forced labour. At the age of 60, it was doubtful that he would survive. Hahn and Nikolaus Riehl arranged for Hoernes to work at the KWIC, claiming that his work was essential to the uranium project and that uranium was highly toxic, making it hard to find people to work with it. Hahn was aware that uranium ore was fairly safe in the laboratory and could be mined safely using the correct equipment and procedures, but the 2,000 female slave labourers from the Sachsenhausen concentration camp who mined it in Oranienburg suffered agonising deaths because their Nazi slavedrivers wilfully neglected their safety. Another physicist with a Jewish wife was Heinrich Rausch von Traubenberg. Hahn certified that his work was important to the war effort, and that his wife Maria, who had a doctorate in physics, was required as his assistant. After he died on 19 September 1944, Maria faced being sent to a concentration camp. Hahn mounted a lobbying campaign to get her released, but to no avail, and she was sent to the Theresienstadt Ghetto in January 1945. She survived the war, and was reunited with her daughters in England.
Sources: en.wikipedia.org
=== Operating systems === AI agents have also been integrated into operating systems developed by Microsoft, Apple, ByteDance, and Google. In November 2025, Microsoft released a test software build of Windows 11 that included agents to run background tasks, with the ability to read and write personal files. In December 2025, ByteDance released Doubao, an AI agent that can be integrated into smartphone operating systems, particularly the Nubia M153 by ZTE. Several apps in China blocked or restricted the agent, citing privacy and security concerns, including WeChat, Alipay, Taobao, Pinduoduo, Ele.me, and local banks.
Irreversible inhibitors first form a reversible non-covalent complex with the enzyme (EI or ESI). Subsequently, a chemical reaction occurs between the enzyme and inhibitor to produce the covalently modified "dead-end complex" EI* (an irreversible covalent complex). The rate at which EI* is formed is called the inactivation rate or kinact. Since formation of EI may compete with ES, binding of irreversible inhibitors can be prevented by competition either with substrate or with a second, reversible inhibitor. This protection effect is good evidence of a specific reaction of the irreversible inhibitor with the active site. The binding and inactivation steps of this reaction are investigated by incubating the enzyme with inhibitor and assaying the amount of activity remaining over time. The activity will be decreased in a time-dependent manner, usually following exponential decay. Fitting these data to a rate equation gives the rate of inactivation at this concentration of inhibitor. This is done at several different concentrations of inhibitor. If a reversible EI complex is involved the inactivation rate will be saturable and fitting this curve will give kinact and Ki. Another method that is widely used in these analyses is mass spectrometry. Here, accurate measurement of the mass of the unmodified native enzyme and the inactivated enzyme gives the increase in mass caused by reaction with the inhibitor and shows the stoichiometry of the reaction. This is usually done using a MALDI-TOF mass spectrometer.
In the 2021 Census of Population conducted by Statistics Canada, the census districts within the former city had a population of 629,941 living in 218,928 of its 228,939 total private dwellings, a change of −0.3% from its 2016 population of 632,098. With a land area of 187.70 square kilometres (72.47 sq mi), it had a population density of 3,356.1 people/km2 (8,692 people/sq mi) in 2021. The majority of the district's population is between 25 and 64 years old. 52% fell into that "working age" during the last major survey, which also found 21% of Scarborough's population was 14 years old or younger, 15% were between 15 and 24, while senior citizens aged 65+ made up the remaining 12%. Like the rest of Canada, the population is aging. It is projected that close to 30% of Scarborough residents will be senior citizens by 2041. Scarborough has a large number of retirement communities, which attracts more seniors to the area creating a situation where the two largest age demographics in Scarborough will be over 55 and under 25.
May 31: Decree regarding the admission of women to the role of Foreign Trade Advisor. June 14: The issuance of a passport no longer requires a husband's authorization for a married woman. September 30: Decree establishing a Higher Council for Child Protection. 1938
by sending weapons to one of the sides) between Russia and Ukraine to negotiate an end to the conflict and invited the US to join Brazil in a new global climate governance On 28 February, Brazilian Environment minister Marina Silva met with John Kerry, the White House envoy for climate change during his visit to Brazil, and announced the resumption of a US-Brazil environment group created in 2015 to debate energy transition, low carbon economy, climate change mitigation, indigenous peoples protection and bioconomy among others between the two countries. Nevertheless, no contribution to the Amazon Fund was announced by Kerry during the visit. In September 2023, Lula and Biden met on the sidelines of the 78th United National General Assembly (UNGA), in New York, to launch an initiative to promote worker's rights. In June 2024, it was reported that Brazil and the US were preparing to launch a joint green transition partnership involving lithium, niobium and other strategic minerals to expand and develop both countries' supply chains.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.